Leading Research Institution Chooses Automation Solution to Meet New HHS Rules CHICAGO -- Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced that Cincinnati Children's Hospital Medical Center...
BALERNA, Switzerland -- APR Applied Pharma Research s.a. ("APR"), Labtec GmbH ("Labtec") and Norgine BV ("Norgine") announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm[TM] Ondansetron...
ROCHESTER, Minn. -- Results of two studies suggest that a new, investigational colorectal cancer screening test developed in a collaboration between Mayo Clinic and Exact Sciences Inc. of Madison, Wis., is highly accurate...
Study also Demonstrated 100% Sustained Virologic Response 12-Weeks Post Treatment with Quadruple Therapy Phase II Investigational Data Published Today in the New England Journal of Medicine PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE:...
Cold adapted and heat-labile unique Enzymes that Improve Molecular Biology TROMSO, Norway -- ArcticZymes AS announced today the formation of ArcticZymes Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. The Company...
WOBURN, Mass. -- ArQule, Inc. (NASDAQ: ARQL) today announced that treatment with tivantinib as single agent therapy produced a statistically significant 56 percent improvement in time-to-progression (TTP) in the intent-to-treat (ITT) population, the...
SHOREVIEW, Minn. -- The LINX[R] Reflux Management System, a novel device for the treatment of Gastroesophageal Reflux Disease (GERD), has received a positive recommendation from the Food and Drug Administration's (FDA) Gastroenterology and...
WALTHAM, Mass. -- Medical Capital Advisors, a specialized mergers and acquisitions consulting firm focused solely on the medical technology industry, today announced that it advised The Musculoskeletal Transplant Foundation (MTF), the world's largest...
RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at The 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2012 at 4:30...
Healthland EHR Reduces Costs, Increases Medical Accuracy and Improves Patient Care HAMBURG, Iowa -- George C. Grape Community Hospital expects to qualify for several hundred thousand dollars in federal reimbursement for implementing and...
ROCHESTER, Minn. -- Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic...
Tokyo, Jan 3, 2012 - (JCN) - Otsuka Medical Devices Co. Ltd (OMD) has acquired a 24.73% stake in Italy-based Era Endoscopy S.r.l. (Era), is a medical device company focused on discovery, development,...
Among the top five on every business owner's list of must-haves when choosing a location are a favorable tax structure, multimodal connections and swell-educated workforce. Florida has these, of course, but we also...
Strengths According to company press, Dexcel is the second-largest supplier of medicines to Israel. History of successful in-house R&D. GMP-compliant production facilities. Around 80% of total sales achieved in overseas markets. Weaknesses Market...
Strengths Leading drugmaker by sales in 2009. Long-established CEE manufacturing base in Bulgaria, Serbia and newly-acquired subsidiary in Hungary. Strong branded generic business in CEE and double-digit sales growth in key markets. Modern...
Company Profiles Indigenous Manufacturers Strengths Sales grew by 9.1% in 2007, by 9.7% in 2008 and by 8.4% in 2009. Increased expenditure and commitment to R&D. Wide-ranging product portfolio, including OTCs. Weaknesses Uncertainty...
SWOT Analysis Strengths Has a strong drug portfolio, with substantial marketing, local experience and capital resources.Has a diverse product portfolio, ranging from OTC medicines to diabetes and HIV/AIDS treatments. The company is focusing...
Strengths Well positioned to grow its share of the pharmaceutical market. Strong product portfolio, including vaccines, antibiotics, dermatologicals and a broad range of vitamins. Launch of Cervarix is set to spark a surge...
Strengths Novartis has capital strength and a diverse business portfolio, comprising ethical drugs, OTCs, eyecare and infant products. Sandoz generic drugs division is well placed to exploit any expansion in the country's legitimate...
Strengths Well established in Australia, with prescription pharmaceuticals as well as a highly recognisable consumer health portfolio. Local manufacturing sites, for both novel pharmaceuticals and for OTCs. Active in local R&D. Well placed...